Well said fc , and agree totally (unless of course the price was too good to refuse, >$1 early stage)
Put to bed for now.
Would much prefer to see this become a Genentech mini me. Partnered with Roche.
Multi product pipeline. Licensing upfronts, milestones , revenue splitting. Reinvesting in new combos.
Who knows what the annual dividend could be, certainly much higher than 10 c ps on even minor success.
